
Cargo Therapeutics rises 2.2% in trading debut after IPO priced at low end of range
The stock of Cargo Therapeutics CRGX, -3.13%, a clinical-stage biotech specializing in cancer treatments, rose 2.2% in its trading debut on Friday. The deal